Literature DB >> 17643985

Emergency transsphenoidal surgery for hemorrhagic pituitary adenomas.

Xiang Zhang1, Zhou Fei, Wei Zhang, Wei-Dong Cao, Wei-Ping Liu, Jian-Ning Zhang, Luo-An Fu, Xiao-Fan Jiang, Hai-Ning Zhen, Shao-Jun Song, Xia Li.   

Abstract

Hemorrhagic pituitary adenoma (HPA) is an acute clinical event in neurosurgery. Emergency surgical decompression is the most effective treatment. We retrospectively reviewed 65 cases collected from the Xijing Institute of Clinical Neuroscience from 1995 to 2005 with HPA. The majority of the patients (81.5%) experienced the acute symptoms of pituitary apoplexy including headache, ocular paresis, visual field deficits and hypopituitarism. On imaging features, 34 adenomas (52.3%) showed marked suprasellar extension, 17 (26.2%) showed moderate extension, and 6 (9.2%) had slight extension, another eight (12.3%) were intrasellar. All patients were treated promptly by emergency surgical decompression usually within 24h after the hospitalization. Twenty four patients operated on by the traditional transsphenoidal microsurgery; whereas 41 patients operated on by the endoscopic endonasal transsphenoidal surgery. Total removal of tumors was achieved in 59 cases (90.8%) and subtotal removal in 6 cases (9.2%). Postoperative radiotherapy, suppressive drug therapy and endocrine replacement therapy were required in seven patients with either remaining tumor or tumor recurrence. In a median follow-up period of 49 months for 54 cases, most patients' clinical symptoms had markedly improved. Visual acuity and visual fields improved in 88.4% and 92.7% of the patients who had preoperative visual symptoms, respectively. The majority of the HPA often occurred in patients with macroadenomas. With emergency surgical treatment, most patients with HPA could have quick improvement of symptoms, especially for altered consciousness and visual acuity or visual fields impairments.

Entities:  

Mesh:

Year:  2007        PMID: 17643985     DOI: 10.1016/j.suronc.2007.06.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  8 in total

1.  Third, Fourth, and Sixth Cranial Nerve Palsies in Pituitary Apoplexy.

Authors:  Rabih Hage; Sheila R Eshraghi; Nelson M Oyesiku; Adriana G Ioachimescu; Nancy J Newman; Valérie Biousse; Beau B Bruce
Journal:  World Neurosurg       Date:  2016-07-17       Impact factor: 2.104

2.  Cavernous hemangioma of the optic chiasm: a surgical review.

Authors:  Matthew Crocker; Ruth Desouza; Andrew King; Steve Connor; Nick Thomas
Journal:  Skull Base       Date:  2008-05

3.  Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy.

Authors:  Ju-Wan Seuk; Choong-Hyun Kim; Moon-Sul Yang; Jin-Hwan Cheong; Jae-Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

4.  Endoscopic Endonasal Transsphenoidal Approach for Apoplectic Pituitary Tumor: Surgical Outcomes and Complications in 45 Patients.

Authors:  Rucai Zhan; Xueen Li; Xingang Li
Journal:  J Neurol Surg B Skull Base       Date:  2015-08-20

5.  The Effect of Timing of Surgery in Pituitary Apoplexy on Continuously Valued Visual Acuity.

Authors:  Patrick D Kelly; Shanik J Fernando; Jordan A Malenke; Rakesh K Chandra; Justin H Turner; Lola B Chambless
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-24

6.  Surgical outcomes of the endoscopic transsphenoidal route to pituitary tumours in paediatric patients >10 years of age: 5 years of experience at a single institute.

Authors:  Rucai Zhan; Guangming Xu; Timothy M Wiebe; Xingang Li
Journal:  Arch Dis Child       Date:  2015-05-25       Impact factor: 3.791

7.  Endoscopic Endonasal Transsphenoidal Treatment of Pituitary Apoplexy: Outcomes in a Series of 20 Patients.

Authors:  Tong Yang; Fatema Bayad; Madeleine R Schaberg; Dimigtri Sigounas; Gurston Nyquist; Gregory Bonci; Kunal Patel; Apostolos John Tsiouris; Vijay K Anand; Theodore H Schwartz
Journal:  Cureus       Date:  2015-10-20

8.  Acute Hemorrhagic Apoplectic Pituitary Adenoma: Endoscopic Management, Surgical Outcomes, and Complications.

Authors:  Rucai Zhan; Yanxin Zhao; Timothy M Wiebe; Xingang Li
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.